ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Background
Trutankless Inc. was incorporated in the state of Nevada on March 7, 2008. The Company is headquartered in Scottsdale, Arizona and currently operates through its wholly owned subsidiaries, Bollente, Inc., a Nevada corporation incorporated on December 3, 2009 and Tankless365, Inc., a Nevada corporation incorporated on October 20, 2021.
Trutankless is involved in sales, marketing, research and development of a high quality, whole-house, smart electric tankless water heater that is more energy efficient than conventional products. See “Item 1. Business.”
RESULTS OF OPERATIONS
Revenues
In the year ended December 31, 2025 we generated $1,082,887 in revenues, as compared to $242,350 in revenues in the prior year. The increase in sales was attributable to the on-goings of the next generation of our trutankless ® residential and light commercial products. Cost of goods sold was $1,040,865, as compared to $279,356 in the prior year.
To the knowledge of management, the Company is unaware of any trends or uncertainties in the sales or costs of our products and services for the periods discussed.
Expenses
Operating expenses totaled $3,612,548 during the year ended December 31, 2025 as compared to $5,183,038 in the prior year. In the year ended December 31, 2025, our expenses primarily consisted of General and Administrative of $908,833, Research and Development of $163,541, Consulting Fees of $2,217,207, Legal and Accounting Fees of $157,500, Audit Fees of $85,000 and Depreciation Expense of $80,467.
General and administrative fees increased by $123,474 from the year ended December 31, 2024 to the year ended December 31, 2025. General and administrative fees increased due to an increase in rent expense of $252,240 offset by decreases in many other general and administrative expenses.
Research and Development decreased by $269,306 from the year ended December 31, 2024 to the year ended December 31, 2025. Research and Development fees decreased as the Company completed Gen3 development and increased sales of this new generation of products.
Consulting fees decreased $1,572,752 from the year ended December 31, 2024 to the year ended December 31, 2025. Consulting fees decreased due to a decrease in stock-based consulting fees.
Legal and accounting fees increased $16,472 from the year ended December 31, 2024 to the year ended December 31, 2025. Legal and accounting fees increased due to an increase in legal and accounting services.
Audit fees increased $55,000 from the year ended December 31, 2024 to the year ended December 31, 2025. Audit fees increased due to a required re-audit by the SEC of the year ended December 31, 2022.
Other Expenses
Other expense decreased by $3,785,874 to $1,180,184 in the year ended December 31, 2025 from $4,966,058 for the year ended December 31, 2025. The decrease was the result of a decrease in financing incentive expense.
Net Loss
In the year ended December 31, 2025, we generated a net loss of $4,750,710, a decrease of $5,435,392 from $10,186,102 for the year ended December 31, 2024. This decrease was attributable to the factors discussed above.
Going Concern
The financial statements included in this filing have been prepared in conformity with generally accepted accounting principles that contemplate the continuance of the Company as a going concern.
Management evaluated all relevant conditions and events that are reasonably known or reasonably knowable, in the aggregate, as of the date the consolidated financial statements are issued and determined that substantial doubt exists about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent on the Company’s ability to generate revenues and raise capital. The Company has not generated sufficient revenues from product sales to provide sufficient cash flows to enable the Company to finance its operations internally. As of December 31, 2025 and 2024, the Company had $21,619 and $1,004,190 cash on hand, respectively. At December 31, 2025 and 2024, the Company has an accumulated deficit of $81,852,679 and $77,101,969, respectively. For the years ended December 31, 2025 and 2024, the Company had a net loss of $4,750,710 and $10,186,102, and cash used in operations of $1,483,173 and $2,315,411, respectively. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year from the date of filing.
Table of Contents
Over the next twelve months management plans to raise additional capital and to invest its working capital resources in sales and marketing in order to increase the distribution and demand for its products. However, there is no guarantee the Company will generate sufficient revenues or raise capital to continue operations. If the Company fails to generate sufficient revenue and obtain additional capital to continue at its expected level of operations, the Company may be forced to scale back or discontinue its sales and marketing efforts. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Liquidity and Capital Resources
At December 31, 2025, we had an accumulated deficit of $81,852,679 and a working capital deficiency of $10,612,370. As of December 31, 2025, we had 21,619 in cash.
Cash Flows from Operating, Investing and Financing Activities
The following table provides detailed information about our net cash flow for all financial statement periods presented in this Annual Report. To date, we have financed our operations through the issuance of stock and borrowings.
The following table sets forth a summary of our cash flows for the years ended December 31, 2025 and 2024:
Years Ended
December 31,
December 31,
Net cash used in operating activities
Net cash used in investing activities
Net cash provided by financing activities
Net increase/(decrease) in Cash
Cash, beginning
Cash, ending
Operating activities
Net cash used in operating activities was $1,483,173 for the year ended December 31, 2025, as compared to $2,315,411 used in operating activities for the same period in 2024. The decrease in net cash used in operating activities was primarily due to the decrease stock issued for services and financing incentives, increase in inventory, decrease in prepaid expenses and the overall decrease in net loss during the year ended December 31, 2025.
Investing activities
Net cash used in investing activities for the year ended December 31, 2025 was $297,691, as compared to $191,917 for the same period of 2024. The increase of net cash used in investing activities was mainly from the purchase of property, plant and equipment during the year ended December 31, 2025.
Table of Contents
Financing activities
Net cash provided by financing activities for the year ended December 31, 2025 was $798,293, as compared to $3,490,066 for the same period of 2024. The decrease of net cash provided by financing activities was mainly due to an increase in notes payable to related parties offset by an increase in payments made on notes payable to related parties during the year ended December 31, 2025.
Ongoing Funding Requirements
As of December 31, 2025, we continue to use traditional and/or debt financing to provide the capital we need to run the business. It is possible that we may need additional funding to enable us to fund our operating expenses and capital expenditures requirements.
Until such time, if ever, as we can generate substantial product revenues, we intend to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. There can be no assurance that any of those sources of funding will be available when needed on acceptable terms or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of existing stockholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us.
If we are unable to raise additional funds through equity or debt financings or relationships with third parties when needed or on acceptable terms, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts; abandon our business strategy of growth through acquisitions; or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.
Critical Accounting Polices
In December 2001, the SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Our critical accounting policies are disclosed in Note 1 of our audited consolidated financial statements included in the Form 10-K filed with the SEC.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.